Governance
As a translational cancer research centre, the Cancer Research UK Manchester Centre functions as a federation with research positions remaining within the relevant University Faculties/Institutes and NHS Trusts. Academics from across Manchester represent the CRUK Manchester Centre in order to drive forward our research agenda and help us to realise our vision.
Overview
The CRUK Manchester Centre is directed by Professor Robert Bristow with Professor Caroline Dive as deputy Director. The day-to-day management is handled by the operations team and is led by Dr Claire Trinder.
Each theme is led by a dedicated theme lead and assisted by a project or programme manager. Across the five research themes and underpinning Digital Cancer Centre and Augmented Core Services, the leads include:
Cancer Biomarkers
Professor Caroline Dive, PhD CBE FMedSci, supported by project manager Ekram Aidaros-Talbot.
Cancer Early Detection
Professor Emma Crosbie, BSc MBChB PhD FRCOG and Dr Philip Crosbie, MBChB PhD FRCP, supported by project managers Dr Martin Bone and Emma Thorpe.
Core Services and Technology Platforms
Mr Stuart Pepper leads on facilitating access to CRUK MI-hosted core technological platforms.
Digital Cancer Centre
Dr Dónal Landers MB BCh BAO BA MBA DPM FFPM PGCert and Professor Corinne Faivre-Finn, FRCR MD PhD.
Experimental Cancer Medicine
Dr Natalie Cook, MBChB PhD MRCP, Dr Matthew Krebs, MBChB PhD MRCP and Professor Fiona Thistlethwaite, BA MA MB BChir PhD MRCP, supported by project manager Dr Amanda Rees.
Integrative Pathology Incorporating the MCRC Biobank
Professor David Wedge BA PGCE MSc PhD and Dr Pedro Oliveira MD, supported by Business Manager of the MCRC Biobank, Jane Rogan.
Radiobiology Adaptive Programme – BioAdaption
Professor Peter Hoskin, BSc MD MRCS FRCR FRCP FACR FFR RCSI, Professor Ananya Choudhury, MA (Cantab) PhD MRCP FRCR, and Professor Marcel van Herk, BSc MSc PhD, supported by programme manager Rebecca Elliott.
Meet the Theme Leads
Caroline Dive
Director, Cancer Biomarker Centre
Theme Lead, Cancer Biomarkers
Emma Crosbie
Professor of Gynaecological Oncology
The University of Manchester
Phil Crosbie
Senior Lecturer
The University of Manchester
Dónal Landers
Strategic Director
Digital ECMT
Corinne Faivre-Finn
Professor of Thoracic Radiation Oncology
The University of Manchester
Natalie Cook
Senior Clinical Lecturer
The Christie
Matthew Krebs
Clinical Senior Lecturer
The University of Manchester
Fiona Thistlethwaite
Medical Oncology Consultant
The Christie
Pedro Oliveira
Consultant in Histopathology
The Christie
David Wedge
Professor of Cancer Genomics and Data Science
The University of Manchester
Ananya Choudhury
Chair and Honorary Consultant
The University of Manchester and The Christie
Marcel Van Herk
Professor of Radiation Physics
The University of Manchester
Peter Hoskin
Professor of Clinical Oncology
The University of Manchester
International Advisory Board
The scientific direction of the CRUK Manchester Centre is assisted by members of an International Advisory Board (IAB). This board convenes annually to assess the CRUK Manchester Centre’s scientific direction, current work and future ambitions. Chaired by Professor David Jaffray, the IAB is constructed from the following members:
International Advisory Board
David Jaffray
Chief Technology and Digital Officer
MD Anderson Cancer Center
Daniel Zips
Chair Radiation Oncology
CCC Tübingen-Stuttgart, University Hospital and Medical Faculty
Henricus De Koning
Deputy Head and Professor of Public Health & Screening Evaluation
Ignacio Melero
Professor of Immunology
Universidad de Navarra
Karen Knudsen
Chief Executive Officer
American Cancer Society
Patricia LoRusso
Professor of Medicine
Yale Cancer Center
Bertrand Tombal
Professor of Urology
Université Catholique de Louvain (UCL)
Sheila Singh
Professor of Surgery and Biochemistry
McMaster Children's Hospital
Navigation
About the CRUK Manchester Centre
The CRUK Manchester Centre is a translational research centre dedicated to delivering precision medicine for all.
Our Vision
Discover more about our vision to deliver cancer precision for all.
Collaborations
To achieve our goals, we need to work collaboratively.